PHARMADVANCE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMADVANCE
Largest movements
- Current investments -€54,573
down €54,573 (-12.7%), from €431,255 to €376,682
- Receivables within one year +€54,356
up €54,356 (+33.2%), from €163,902 to €218,257
of which Other amounts receivable: +€28,766
- Cash +€38,976
up €38,976 (+382.7%), from €10,185 to €49,161
mainly Other debts (+€60,667) and Current investments (+€54,573)
- Intangible fixed assets -€28,000
down €28,000 (-50.0%), from €56,000 to €28,000
- Tangible fixed assets -€24,381
down €24,381 (-7.7%), from €316,863 to €292,481
of which Land and buildings: -€19,503
- Debts after one year -€89,000
down €89,000 (-26.3%), from €338,000 to €249,000
- Other debts +€60,667
up €60,667 (+71.4%), from €84,982 to €145,649
- Profit (loss) carried forward +€31,820
up €31,820 (+78.2%), from €40,715 to €72,536
- Trade debts -€18,800
down €18,800 (-4.0%), from €466,688 to €447,888
- Tax, wage and social debts -€12,579
down €12,579 (-24.5%), from €51,350 to €38,771
of which Remuneration and social security: -€14,886
- Staff costs -€33,550
down €33,550 (-15.8%), from €212,954 to €179,404
- Gross operating margin -€29,419
down €29,419 (-8.9%), from €328,716 to €299,297
- Financial income +€21,256
up €21,256 (+58.9%), from €36,118 to €57,374
- Other operating charges -€7,877
down €7,877 (-85.4%), from €9,220 to €1,343
- Taxes +€5,046
up €5,046 (+22.2%), from €22,684 to €27,730
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,094,070 | €1,066,496 | -€27,574 | -2.5% |
| Fixed assets | 21/28 | €372,863 | €320,481 | -€52,381 | -14.0% |
| Intangible fixed assets | 21 | €56,000 | €28,000 | -€28,000 | -50.0% |
| Tangible fixed assets | 22/27 | €316,863 | €292,481 | -€24,381 | -7.7% |
| Land and buildings | 22 | €294,099 | €274,596 | -€19,503 | -6.6% |
| Plant, machinery and equipment | 23 | €15,336 | €13,608 | -€1,729 | -11.3% |
| Furniture and vehicles | 24 | €7,428 | €4,277 | -€3,150 | -42.4% |
| Current assets | 29/58 | €721,207 | €746,015 | +€24,807 | +3.4% |
| Stocks and contracts in progress | 3 | €113,862 | €99,915 | -€13,946 | -12.2% |
| Stocks | 30/36 | €113,862 | €99,915 | -€13,946 | -12.2% |
| Amounts receivable within one year | 40/41 | €163,902 | €218,257 | +€54,356 | +33.2% |
| Trade receivables | 40 | €135,010 | €160,599 | +€25,590 | +19.0% |
| Other amounts receivable | 41 | €28,892 | €57,658 | +€28,766 | +99.6% |
| Current investments | 50/53 | €431,255 | €376,682 | -€54,573 | -12.7% |
| Cash at bank and in hand | 54/58 | €10,185 | €49,161 | +€38,976 | +382.7% |
| Deferred charges and accrued income | 490/1 | €2,004 | €1,999 | -€5 | -0.3% |
| Total equity and liabilities | 10/49 | €1,094,070 | €1,066,496 | -€27,574 | -2.5% |
| Equity | 10/15 | €59,315 | €91,136 | +€31,820 | +53.6% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | €40,715 | €72,536 | +€31,820 | +78.2% |
| Amounts payable | 17/49 | €1,034,755 | €975,360 | -€59,395 | -5.7% |
| Amounts payable after more than one year | 17 | €338,000 | €249,000 | -€89,000 | -26.3% |
| Financial debts | 170/4 | €338,000 | €249,000 | -€89,000 | -26.3% |
| Amounts payable within one year | 42/48 | €696,755 | €726,360 | +€29,605 | +4.2% |
| Current portion of amounts payable after more than one year | 42 | €89,000 | €89,000 | = | 0.0% |
| Financial debts | 43 | €4,735 | €5,052 | +€317 | +6.7% |
| Credit institutions | 430/8 | €4,735 | €5,052 | +€317 | +6.7% |
| Trade debts | 44 | €466,688 | €447,888 | -€18,800 | -4.0% |
| Suppliers | 440/4 | €466,688 | €447,888 | -€18,800 | -4.0% |
| Taxes, remuneration and social security | 45 | €51,350 | €38,771 | -€12,579 | -24.5% |
| Taxes | 450/3 | €6,117 | €8,424 | +€2,307 | +37.7% |
| Remuneration and social security | 454/9 | €45,233 | €30,347 | -€14,886 | -32.9% |
| Other amounts payable | 47/48 | €84,982 | €145,649 | +€60,667 | +71.4% |
| Remuneration, social security and pensions | 62 | €212,954 | €179,404 | -€33,550 | -15.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €53,847 | €52,833 | -€1,014 | -1.9% |
| Other operating charges | 640/8 | €9,220 | €1,343 | -€7,877 | -85.4% |
| Gross operating margin | 9900 | €328,716 | €299,297 | -€29,419 | -8.9% |
| Operating profit (loss) | 9901 | €52,695 | €65,716 | +€13,021 | +24.7% |
| Financial income | 75/76B | €36,118 | €57,374 | +€21,256 | +58.9% |
| Recurring financial income | 75 | €36,118 | €57,374 | +€21,256 | +58.9% |
| Financial charges | 65/66B | €54,590 | €51,539 | -€3,050 | -5.6% |
| Recurring financial charges | 65 | €54,590 | €51,539 | -€3,050 | -5.6% |
| Profit (loss) for the period before taxes | 9903 | €34,224 | €71,550 | +€37,327 | +109.1% |
| Income taxes | 67/77 | €22,684 | €27,730 | +€5,046 | +22.2% |
| Profit (loss) for the period | 9904 | €11,539 | €43,820 | +€32,281 | +279.7% |
| Profit (loss) for the period to be appropriated | 9905 | €11,539 | €43,820 | +€32,281 | +279.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.